NuVasive Inc. (NUVA)

49.15 -0.37 (-0.747%)

IEX Real-Time Price

May 22, 2018 EST.

Nasdaq Global Select : Healthcare

Prev Close 49.52

Price Open 49.61

Volume: 276,120

Avg Volume: 790,366

Market Cap: 2.52B

P/E Ratio 25.47

52 Wk Range 44.62-81.6792



NUVA Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-04-30
47.25M
5.12M
6.31
10.85%

2018-04-13
47.25M
6.73M
9.56
14.24%

2018-03-29
47.25M
4.66M
7.96
9.86%

2018-03-15
47.25M
4.86M
7.11
10.28%




NUVA Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-01
Q1 2018
AMC
0.45 (10)
0.39
-0.06

2018-04-24
Q1 2018
N/A
0.45 (10)
0.39
-0.06

2018-02-26
Q4 2017
AMC
0.56 (9)
0.39
-0.06

2018-02-08
Q4 2017
N/A
0.56 (9)
0.39
-0.06

News

K2M Disrupting The Market, Growing, And Still Undervalued (2018-05-22 09:13 SeekingAlpha)

Innovation can still produce results even in a sluggish U.S. spine market, as seen with the ongoing growth at companies like K2M ( KTWO ) and Globus ( GMED ). In the case of K2M, the story is still about the company's disruptive product development in degenerative and complex spine, suppor…

 

NuVasive Not Getting, Or Deserving, The Benefit Of The Doubt Yet (2018-05-22 08:49 SeekingAlpha)

Investors remain reluctant to give NuVasive ( NUVA ) much benefit of the doubt, and based upon the companys recent performance, I cant say I blame them. Although I wrote back in January that I thought it would take time for the company to rebuild investor confidence, I …

 

NuVasive PRECICE STRYDE(TM) System Used In First Patient For Stature Lengthening By International Limb Lengthening Expert (2018-05-22 08:30 PR Newswire)

SAN DIEGO , May 22, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the new PRECICE STRYDE system from NuVasive Spec…

 

NuVasive Sponsors SOLAS 2018, Hosts Workshop On Latest Lateral Innovations (2018-05-16 16:02 PR Newswire)

SAN DIEGO , May 16, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that the Company is a sponsor of theSociety of Later…

 

NuVasive To Present At The Bank of America Merrill Lynch 2018 Healthcare Conference (2018-05-09 16:02 PR Newswire)

SAN DIEGO , May 9, 2018 /PRNewswire/ --NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will present at the Bank of America Me…

 


Statistics

Shares Outstanding: 51.26M

Top 15 Institution Percent: N/A

Price To Sales: 2.42

Price To Book: 3.30

Revenue: 508.00M

Gross Profit: 376.00M

Cash: 193.13M

Debt: 1.28B

Return On Assets: 2.49

Return On Equity: 5.55

Profit Margin: 4.05

Price History

Beta: 0.33

50-day Moving Avg: 51.84

200-day Moving Avg: 54.93

YTD Change: -19.19

5-day Change: 1.12

1-month Change: -6.60

3-month Change: 4.43

6-month Change: -11.51

1-year Change: -30.78

Revenue Per Share: 10.00

Revenue Per Employee: 267371.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: NuVasive Inc.

Exchange: Nasdaq Global Select

Industry: Medical Devices

Sector: Healthcare

Website: http://www.nuvasive.com

NuVasive Inc is a medical device company. It develops minimally-disruptive surgical products and procedurally-integrated solutions for the spine. Its product portfolio is focused on applications for spine fusion surgery.